QGEN Qiagen N.V.
$50.37▼ -0.01%
Healthcare
Other
Volume 685.0K
Avg Volume (10D) 8.33M
Key Metrics & Fundamentals
Market Cap
$10.40B
P/E Ratio
25.6
Div Yield
0.69%
52W Range
32.53 - 57.82
% vs 50 MA
13.00%
% vs 200 MA
18.41%
RSI-14
74.3
MACD Histogram
+0.5000
Beta (1Y vs SPY)
0.46
Free Cash Flow
$157.32M
Gross Rev
$535.04M
Gross Profit
$340.39M
EBITDA
$201.93M
COGS
$194.65M
Operating Exp
$199.54M
Operating Income
$140.85M
EBIT
$140.85M
Pretax Income
$132.11M
Net Income
$103.40M
EPS (Diluted)
0.50
Price & Volume History
Loading chart…
Recent News

Global DNA Sequencing in Drug Discovery Market Report 2026 | Capitalize on 12.5% CAGR as Illumina, Thermo Fisher, QIAGEN, and Oxford Nanopore Accelerate AI-Driven Precision R&D
GlobeNewswire · Oct 26, 2026 10:36 AM ET

Can EQT (OM:EQT) Still Be Undervalued Or Is Growth Priced In?
Simply Wall St. · Oct 24, 2026 1:14 AM ET
Qiagen agrees to private equity takeover
MedTech Dive · Oct 23, 2026 9:00 AM ET
Baird Downgrades QIAGEN to Neutral From Outperform, $52 Price Target
MT Newswires · Oct 23, 2026 7:06 AM ET
Sector Update: Healthcare Stocks Gain Late Afternoon
MT Newswires · Oct 22, 2026 3:56 PM ET
Sector Update: Healthcare Stocks Advance Thursday Afternoon
MT Newswires · Oct 22, 2026 1:44 PM ET
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Thursday
MT Newswires · Oct 22, 2026 9:15 AM ET

Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Block, Constellation Energy, Dick’s Sporting Goods, Dutch Bros, Halliburton Company, Netflix, Southern Company,Tesla, and More
24/7 Wall St. · Oct 22, 2026 8:15 AM ET
JPMorgan Downgrades QIAGEN to Neutral, Price Target is $52
MT Newswires · Oct 22, 2026 8:00 AM ET
Berenberg Raises Price Target on QIAGEN to $52.22 From $45.50, Keeps Hold Rating
MT Newswires · Oct 22, 2026 6:39 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See QGEN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.